Raymond James & Associates ACTINIUM PHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 28, 2020
SELL
N/A
-15,325 Closed
0 $0
Q1 2019

May 06, 2019
SELL
N/A
-1,000 Reduced 6.13%
15,325 $7,000
Q4 2018

Feb 11, 2019
BUY
N/A
16,325 New
16,325 $6,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email